Article Information
History
- May 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Keren Papier1,*,
- Anika Knuppel1,
- Aurora Perez-Cornago1,
- Eleanor L. Watts1,
- Tammy YN Tong1,
- Julie A Schmidt1,
- Naomi Allen2,
- Timothy J Key1 and
- Ruth C Travis1
- 1Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
- 2Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
- ↵*Correspondence to:
Dr Keren Papier (Keren.Papier{at}ndph.ox.ac.uk) T: +44 (0)1865 289684 Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Richard Doll Building, Roosevelt Drive, Oxford OX3 7LF, UK
Posted May 10, 2021.
Circulating insulin-like growth factor-I and risk of 25 common conditions: outcome-wide analyses in the UK Biobank Study
